Imaging α-Synuclein in the Brain: [18F]ACI-15916

We are testing a new imaging agent to see if it can help identify α-synuclein deposits in the brains of patients suspected of having related conditions. Healthy volunteers are also included to compare results.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Karolinska Institutet
Clinical Neuroscience
Solna, Sweden
Sponsor: AC Immune S.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.